Lumira Capital co-leads $34 mln financing of Spinal Kinetics

Spinal Kinetics Inc has obtained US$34 million in new financing. Canadian life sciences venture capital firm Lumira Capital was one of the company's existing investors that led the deal. The others were U.S. firms Scale Venture Partners, De Novo Ventures, SV Life Sciences and HLM Ventures. Based in Sunnyvale, California, Spinal Kinetics is a medical device company focused on treatment of diseases of the spine. Funds raised will be used primarily to initiate an FDA-approved clinical trial of the company's M6-C artificial cervical disc and expand global commercialization and clinical programs.

CanadaNorth AmericaBriefs